Fol. Biol. 2025, 71, 256-261
Low Statin Doses Have No Effect on Plasma Concentrations of cfDNA or Muscle-Specific miRNA
, Jaroslav A. Hubáček1,2, Kristýna Janoušková2, Dana Dlouhá2, Jiří Laštůvka3, Věra Adámková2
1Third Department of Medicine – Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
2Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
3Krajská zdravotní a. s., Masaryk Hospital in Ústí nad Labem, Ústí nad Labem, Czech Republic
Received December 3, 2025
Accepted January 7, 2026
Individual author index pages
Other articles of these authors
-
Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes
Michal Vrablík, J. A. Hubáček, D. Dlouha, M. Satny, V. Adámková, R. Češka
2019, Vol. 65, Issue 4, pp. 188-194 -
Can Leukocyte Telomere Length Predict Survival Time in Heart Transplant Recipients over a Minimal Follow-Up of 20 years?
Dana Dlouhá, V. Vančura, J. Vymětalová, J. A. Hubáček, V. Lánská, I. Málek
2016, Vol. 62, Issue 5, pp. 188-193 -
CD14 Polymorphism Is Not Associated with SARS-CoV-2 Infection in Central European Population
Jaroslav A. Hubáček, Tom Philipp, Ondřej Májek, Dana Dlouhá, Věra Adámková, Ladislav Dušek
2023, Vol. 69, Issue 5-6, pp. 181-185 -
Nobody Is Perfect: Comparison of the Accuracy of PCR-RFLP and KASP™ Method for Genotyping. ADH1B and FTO Polymorphisms as Examples
Jaroslav A. Hubáček, H. Pikhart, A. Peasey, R. Kubínová, M. Bobák
2015, Vol. 61, Issue 4, pp. 156-160 -
Tagging rs10811661 Variant at CDKN2A/2B Locus Is Not Associated with Type 2 Diabetes Mellitus in Czech Population
Jaroslav A. Hubáček, T. Neškudla, M. Klementová, V. Adámková, T. Pelikánová
2013, Vol. 59, Issue 4, pp. 168-171 -
Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population
Jaroslav A. Hubáček, V. Staněk, M. Gebauerová, R. Poledne, M. Aschermann, H. Skalická, J. Matoušková, A. Kruger, M. Pěnička, H. Hrabáková, J. Veselka, P. Hájek, V. Lánská, V. Adámková, J. Piťha
2012, Vol. 58, Issue 5, pp. 203-208 -
INSIG2 G-102A Promoter Variant Exhibits Context-Dependent Effect on HDL-Cholesterol Levels but Not on BMI in Caucasians
Jaroslav A. Hubáček, P. Suchánek, V. Lánská, J. Piťha, V. Adámková
2011, Vol. 57, Issue 4, pp. 170-172 -
INSIG2 Promoter Variant, Obesity Markers and Lipid Parameters – No Association in a Large Slavonic Caucasian Population Sample
Jaroslav A. Hubáček, L. Kuthanová, R. Bohuslavová, V. Adámková, V. Lánská, T. Meitinger, A. Pfeufer
2010, Vol. 56, Issue 3, pp. 131-134 -
Apolipoprotein E Arg136 → Cys in Individuals with Premature Myocardial Infarction
Jaroslav A. Hubáček, R. Poledne, J. Piťha, M. Aschermann, H. Skalická, V. Staněk
2009, Vol. 55, Issue 3, pp. 116-118 -
Differences in Expression of Cholesterol 7α-Hydroxylase between PHHC and Wistar Rats
Jaroslav A. Hubáček, D. Bobková, R. Bohuslavová, R. Poledne
2008, Vol. 54, Issue 1, pp. 18-23 -
Variants within the Ghrelin Gene - Association with HDL-Cholesterol, but Not with Body Mass Index
Jaroslav A. Hubáček, R. Bohuslavová, Z. Škodová, V. Adámková
2007, Vol. 53, Issue 6, pp. 202-206 -
Selected Genetic Characteristics of the Vietnamese Minority Living in the Czech Republic
Khanh Ha Pham, Jaroslav A. Hubáček
2025, Vol. 71, Issue 1, pp. 1-7
